Structures of aminophenol dioxygenase in complex with intermediate, product and inhibitor

Dioxygen activation by nonhaem Fe(II) enzymes containing the 2‐His‐1‐carboxylate facial triad has been extensively studied in recent years. Here, crystal structures of 2‐aminophenol 1,6‐dioxygenase, an enzyme that represents a minor group of extradiol dioxygenases and that catalyses the ring opening...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta crystallographica. Section D, Biological crystallography. Biological crystallography., 2013-01, Vol.69 (1), p.32-43
Hauptverfasser: Li, De-Feng, Zhang, Jia-Yue, Hou, Yan-Jie, Liu, Lei, Hu, Yonglin, Liu, Shuang-Jiang, Wang, Da-Cheng, Liu, Wei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Dioxygen activation by nonhaem Fe(II) enzymes containing the 2‐His‐1‐carboxylate facial triad has been extensively studied in recent years. Here, crystal structures of 2‐aminophenol 1,6‐dioxygenase, an enzyme that represents a minor group of extradiol dioxygenases and that catalyses the ring opening of 2‐aminophenol, in complex with the lactone intermediate (4Z,6Z)‐3‐iminooxepin‐2(3H)‐one and the product 2‐aminomuconic 6‐semialdehyde and in complex with the suicide inhibitor 4‐nitrocatechol are reported. The Fe–ligand binding schemes observed in these structures revealed some common geometrical characteristics that are shared by the published structures of extradiol dioxygenases, suggesting that enzymes that catalyse the oxidation of noncatecholic compounds are very likely to utilize a similar strategy for dioxygen activation and the fission of aromatic rings as the canonical mechanism. The Fe‐ligation arrangement, however, is strikingly enantiomeric to that of all other 2‐His‐1‐carboxylate enzymes apart from protocatechuate 4,5‐dioxygenase. This structural variance leads to the generation of an uncommon O−—Fe2+—O− species prior to O2 binding, which probably forms the structural basis on which APD distinguishes its specific substrate and inhibitor, which share an analogous molecular structure.
ISSN:1399-0047
0907-4449
1399-0047
DOI:10.1107/S0907444912042072